EMA Authorised: Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate) — Zentiva k.s.

View source ↗

Summary

The European Medicines Agency authorised Tenofovir disoproxil Zentiva for HIV infections; the active substance is tenofovir disoproxil phosphate and Zentiva k.s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Zentiva k.s.. Decision date: 19/03/2025